Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid is a synthetic small molecule belonging to the class of phenoxyacetic acid derivatives. It has been investigated as an experimental compound, primarily in drug discovery and research settings, but it is not approved for clinical use in any country. There are no known approved indications or marketed formulations for this compound. Its mechanism of action and pharmacological targets have not been established or reported in the literature[1][4]. The compound is structurally related to other phenoxyacetic acids, which are sometimes explored for lipid-lowering or other metabolic effects, but there is no evidence that this specific molecule has such activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid.